Loading...

JP Morgan loses $2B, FDA backs HIV prevention drug

|JPMorgan Chase has admitted to massive losses in risky trades in exotic investments costing it $2 billion; Then, The FDA is considering the use of Truvada to prevent the contraction of HIV; Also, a high school principal is teaching kids the way out of poverty.